Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial

✍ Scribed by A A Ezzat; E M Ibrahim; R K Stuart; D Ajarim; S Bazarbashi; M O El-Foudeh; M Rahal; A Al-Sayed; John Berry

• Publisher: Springer US
• Year: 2000
• Tongue: English
• Weight: 762 KB
• Volume: 17
• Category: Article
• ISSN: 1357-0560
• DOI: 10.1007/bf02826215